mind body system glp 1 From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs)

If confirmed by a clinical trial, this could inform the clinical application of metformin such that, for example, drugs known to interact with OCT1 could be replaced with alternatives, allowing improved tolerance to metformin and enabling optimal metformin dosing

Tirzepatide has been available since 2022, with extensive global clinical experience and FDA approval

Limited clinical data support the combination for weight loss, and both drugs independently reduce appetite, potentially amplifying side effects

persistent use of generic levothyroxine on TSH goal achievement: a retrospective study among patients with hypothyroidism in a managed care setting

Impaired leptin signalling in obesity: is leptin a new thermolipokine